Are antithrombin prescriptions in ICUs appropriate? a new study investigates

NCT ID NCT07276074

First seen Jan 05, 2026 · Last updated May 12, 2026 · Updated 18 times

Summary

This study looks back at how antithrombin, a blood protein that helps prevent clots, was prescribed to 160 adult patients in intensive care or operating rooms at Strasbourg University Hospitals over one year. The goal is to understand if these prescriptions were appropriate and how they were used, especially in patients on blood thinners or undergoing procedures like dialysis or heart-lung bypass. No new treatments are given; the study simply reviews existing medical records.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTITHROMBINEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Service d'Anesthésie et Réanimation chirurgicale - CHU de Strasbourg - France

    RECRUITING

    Strasbourg, France

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.